Drugs in development for tuberculosis (Q37809841)

From Wikidata

Jump to navigation Jump to search

scientific article published on December 2010

edit

Language	Label	Description	Also known as
English	Drugs in development for tuberculosis	scientific article published on December 2010

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

21080738

retrieved

23 August 2017

title

Drugs in development for tuberculosis (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

21080738

retrieved

23 August 2017

main subject

tuberculosis

0 references

author name string

Ann M Ginsberg

series ordinal

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

21080738

retrieved

23 August 2017

publication date

1 December 2010

1 reference

stated in

Europe PubMed Central

PubMed publication ID

21080738

retrieved

23 August 2017

published in

Drugs

1 reference

stated in

Europe PubMed Central

PubMed publication ID

21080738

retrieved

23 August 2017

volume

70

1 reference

stated in

Europe PubMed Central

PubMed publication ID

21080738

retrieved

23 August 2017

issue

17

1 reference

stated in

Europe PubMed Central

PubMed publication ID

21080738

retrieved

23 August 2017

page(s)

2201-2214

1 reference

stated in

Europe PubMed Central

PubMed publication ID

21080738

retrieved

23 August 2017

cites work

Investigations into the mechanism of action of the antibacterial agent norfloxacin

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.2165%2F11538170-000000000-00000

retrieved

21 January 2018

Pharmacokinetics-pharmacodynamics of rifampin in an aerosol infection model of tuberculosis

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/21080738

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Linezolid in the treatment of multidrug-resistant tuberculosis

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/21080738

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

In vitro and in vivo activities of moxifloxacin and clinafloxacin against Mycobacterium tuberculosis.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/21080738

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identification of a new antitubercular drug candidate, SQ109, from a combinatorial library of 1,2-ethylenediamines

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/21080738

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Daily dosing of rifapentine cures tuberculosis in three months or less in the murine model

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/21080738

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Non-clinical efficacy and safety of HyVac4:IC31 vaccine administered in a BCG prime-boost regimen

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/21080738

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Outpatient gatifloxacin therapy and dysglycemia in older adults

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/21080738

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Moxifloxacin and glucose homeostasis: a pooled-analysis of the evidence from clinical and postmarketing studies

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/21080738

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Linezolid: a review of safety and tolerability

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/21080738

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

PA-824 kills nonreplicating Mycobacterium tuberculosis by intracellular NO release

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/21080738

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Addition of PNU-100480 to first-line drugs shortens the time needed to cure murine tuberculosis.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/21080738

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Repeated administration of high-dose intermittent rifapentine reduces rifapentine and moxifloxacin plasma concentrations

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/21080738

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

New vaccines against tuberculosis

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/21080738

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Moxifloxacin versus ethambutol in the first 2 months of treatment for pulmonary tuberculosis

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/21080738

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Biology of bacterial deoxyribonucleic acid topoisomerases

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/21080738

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

In vitro and in vivo activities of gatifloxacin against Mycobacterium tuberculosis

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/21080738

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism: novel insights into drug mechanisms of action

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/21080738

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cardiotoxicity of fluoroquinolones

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/21080738

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Double-blind, randomized, placebo-controlled Phase I Clinical Trial of the therapeutical antituberculous vaccine RUTI.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/21080738

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Studies on the treatment of tuberculosis undertaken by the British Medical Research Council tuberculosis units, 1946-1986, with relevant subsequent publications

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/21080738

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The diarylquinoline TMC207 for multidrug-resistant tuberculosis

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/21080738

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Gatifloxacin and moxifloxacin: two new fluoroquinolones

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/21080738

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Early bactericidal activity of high-dose rifampin in patients with pulmonary tuberculosis evidenced by positive sputum smears

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/21080738

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A retrospective TBNET assessment of linezolid safety, tolerability and efficacy in multidrug-resistant tuberculosis

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/21080738

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Efficacy and tolerability of daily-half dose linezolid in patients with intractable multidrug-resistant tuberculosis

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/21080738

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

In vitro interactions between new antitubercular drug candidates SQ109 and TMC207.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/21080738

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Moxifloxacin versus ethambutol in the initial treatment of tuberculosis: a double-blind, randomised, controlled phase II trial

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/21080738

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Early and extended early bactericidal activity of linezolid in pulmonary tuberculosis

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/21080738

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Substitution of moxifloxacin for isoniazid during intensive phase treatment of pulmonary tuberculosis.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/21080738

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Combinations of R207910 with drugs used to treat multidrug-resistant tuberculosis have the potential to shorten treatment duration

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/21080738

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Immunotherapy with Mycobacterium vaccae in the treatment of tuberculosis

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/21080738

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Early and extended early bactericidal activity of levofloxacin, gatifloxacin and moxifloxacin in pulmonary tuberculosis

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/21080738

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

In vitro activity of moxifloxacin, levofloxacin, gatifloxacin and linezolid against Mycobacterium tuberculosis

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/21080738

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

New vaccines for tuberculosis

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/21080738

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Assessment of global capacity to conduct tuberculosis drug development trials: do we have what it takes?

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/21080738

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

OPC-67683, a nitro-dihydro-imidazooxazole derivative with promising action against tuberculosis in vitro and in mice

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/21080738

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Powerful bactericidal and sterilizing activity of a regimen containing PA-824, moxifloxacin, and pyrazinamide in a murine model of tuberculosis

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/21080738

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Assessment of the effects of the nitroimidazo-oxazine PA-824 on renal function in healthy subjects

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/21080738

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Sterilizing activities of fluoroquinolones against rifampin-tolerant populations of Mycobacterium tuberculosis

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/21080738

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Drug therapy of experimental tuberculosis (TB): improved outcome by combining SQ109, a new diamine antibiotic, with existing TB drugs

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/21080738

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Selectivity of TMC207 towards mycobacterial ATP synthase compared with that towards the eukaryotic homologue

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/21080738

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Safety, tolerability, and pharmacokinetics of PA-824 in healthy subjects

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/21080738

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Activity of moxifloxacin against mycobacteria

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/21080738

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The quest for biomarkers in tuberculosis

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/21080738

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Daily 300 mg dose of linezolid for the treatment of intractable multidrug-resistant and extensively drug-resistant tuberculosis.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/21080738

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Moxifloxacin, ofloxacin, sparfloxacin, and ciprofloxacin against Mycobacterium tuberculosis: evaluation of in vitro and pharmacodynamic indices that best predict in vivo efficacy

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/21080738

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Fluoroquinolone toxicity profiles: a review focusing on newer agents

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/21080738

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Enhanced bactericidal activity of rifampin and/or pyrazinamide when combined with PA-824 in a murine model of tuberculosis

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/21080738

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The early bactericidal activity of drugs in patients with pulmonary tuberculosis

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/21080738

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Preclinical testing of the nitroimidazopyran PA-824 for activity against Mycobacterium tuberculosis in a series of in vitro and in vivo models

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/21080738

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Rifampicin reduces plasma concentrations of moxifloxacin in patients with tuberculosis

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/21080738

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Early bactericidal activity and pharmacokinetics of PA-824 in smear-positive tuberculosis patients

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/21080738

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Synergistic interactions of SQ109, a new ethylene diamine, with front-line antitubercular drugs in vitro

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/21080738

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Controlled clinical trial of short-course (6-month) regimens of chemotherapy for treatment of pulmonary tuberculosis

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/21080738

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Quinolone-induced QT interval prolongation: a not-so-unexpected class effect

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/21080738

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

HIV infection-related tuberculosis: clinical manifestations and treatment

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/21080738

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Synergistic activity of R207910 combined with pyrazinamide against murine tuberculosis

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/21080738

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Biomarkers and diagnostics for tuberculosis: progress, needs, and translation into practice

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/21080738

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Immunological consequences of three doses of heat-killed Mycobacterium vaccae in the immunotherapy of tuberculosis

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/21080738

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Diarylquinolines are bactericidal for dormant mycobacteria as a result of disturbed ATP homeostasis

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/21080738

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of cavitary and infiltrating pulmonary tuberculosis with and without the immunomodulator Dzherelo

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/21080738

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of rifampin and multidrug resistance gene polymorphism on concentrations of moxifloxacin

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/21080738

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

In vitro antimycobacterial spectrum of a diarylquinoline ATP synthase inhibitor

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/21080738

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Combination chemotherapy with the nitroimidazopyran PA-824 and first-line drugs in a murine model of tuberculosis

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/21080738

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A diarylquinoline drug active on the ATP synthase of Mycobacterium tuberculosis

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/21080738

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A small-molecule nitroimidazopyran drug candidate for the treatment of tuberculosis

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/21080738

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Toward an optimized therapy for tuberculosis? Drugs in clinical trials and in preclinical development

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/21080738

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Gatifloxacin and ethionamide as the foundation for therapy of tuberculosis

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/21080738

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Bactericidal activity of the nitroimidazopyran PA-824 in a murine model of tuberculosis

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/21080738

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Bactericidal activities of the pyrrole derivative BM212 against multidrug-resistant and intramacrophagic Mycobacterium tuberculosis strains

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/21080738

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Emergence of Mycobacterium tuberculosis with extensive resistance to second-line drugs--worldwide, 2000-2004.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/21080738

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Role of metronidazole in improving response and specific drug sensitivity in advanced pulmonary tuberculosis

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/21080738

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cytokines as immunomodulators in tuberculosis therapy.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/21080738

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Tuberculosis control and elimination 2010–50: cure, care, and social development

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/21080738

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identification of a nitroimidazo-oxazine-specific protein involved in PA-824 resistance in Mycobacterium tuberculosis

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/21080738

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Hypersensitivity reactions to rifampin. Pathogenetic mechanisms, clinical manifestations, management strategies, and review of the anaphylactic-like reactions

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/21080738

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Activities of several novel oxazolidinones against Mycobacterium tuberculosis in a murine model

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/21080738

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacokinetics and whole-blood bactericidal activity against Mycobacterium tuberculosis of single doses of PNU-100480 in healthy volunteers.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/21080738

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

In vitro activities of linezolid against clinical isolates of Mycobacterium tuberculosis that are susceptible or resistant to first-line antituberculous drugs

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/21080738

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A Phase II study of the sterilising activities of ofloxacin, gatifloxacin and moxifloxacin in pulmonary tuberculosis

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/21080738

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Early bactericidal activity and pharmacokinetics of the diarylquinoline TMC207 in treatment of pulmonary tuberculosis

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/21080738

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Diarylquinolines target subunit c of mycobacterial ATP synthase

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/21080738

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

DOI

10.2165/11538170-000000000-00000

1 reference

stated in

Europe PubMed Central

PubMed publication ID

21080738

retrieved

23 August 2017

Dimensions Publication ID

1019705937

0 references

PubMed publication ID

21080738

1 reference

stated in

Europe PubMed Central

PubMed publication ID

21080738

retrieved

23 August 2017

 

Sitelinks

Wikipedia(0 entries)

edit

Wikibooks(0 entries)

edit

Wikinews(0 entries)

edit

Wikiquote(0 entries)

edit

Wikisource(0 entries)

edit

Wikiversity(0 entries)

edit

Wikivoyage(0 entries)

edit

Wiktionary(0 entries)

edit

Multilingual sites(0 entries)

edit

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37809841&oldid=2200972559"